Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism.

María Belén ZanchettaDamián RobbianiBeatriz OliveriEvangelina GiacoiaAdriana FrigeriSilvia KallsbrumHelena SalerniSabrina LucasAdriana DiazBetiana PerezLuisina PieroniMaría Auxiliadora Arce LangeSilvina TormoAriela KitaigrodskyAna María Galich

Published in: Journal of the Endocrine Society (2020)

Although these patients were followed-up by experienced physicians, clinical management was heterogeneous and probably insufficient to assess all the potential complications of this chronic disease. Almost 70% of the study's group of patients met the experts' indications for considering the use of rhPTH 1-84. Being aware of this fact is the 1st step in improving our medical management of this disease in the future.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
risk factors
risk assessment